Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 16 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 17, 2023 Filed Jan 18, 2023 22:08 UTC |
Anderson Bonnie HDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 34,000 | $0.00 Strike: $5.61 | $0.00 |
DisclosureSEC source: 0001384101-23-000004 · wf-form4_167407967323620.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,117 Underlying: Common Stock · 34,000 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:08 UTC |
Anderson Bonnie HDirector
|
SaleCommon Stock | 4,494 | $26.64 | $119,726.45 |
DisclosureSEC source: 0001384101-23-000004 · wf-form4_167407967323620.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,961 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.59 to $26.70. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:08 UTC |
Anderson Bonnie HDirector
|
SaleCommon Stock | 29,506 | $26.30 | $776,111.07 |
DisclosureSEC source: 0001384101-23-000004 · wf-form4_167407967323620.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,455 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.58 to $26.58. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:08 UTC |
Anderson Bonnie HDirector
|
Exercise / conversionCommon Stock | 34,000 | $5.61 | $190,740.00 |
DisclosureSEC source: 0001384101-23-000004 · wf-form4_167407967323620.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 22:27 UTC |
Anderson Bonnie HDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 63,247 | $0.00 Strike: $14.34 | $0.00 |
DisclosureSEC source: 0001384101-23-000002 · wf-form4_167356241552627.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,753 Underlying: Common Stock · 63,247 shares Expires 2024-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 22:27 UTC |
Anderson Bonnie HDirector
|
SaleCommon Stock | 63,247 | $25.13 | $1,589,194.72 |
DisclosureSEC source: 0001384101-23-000002 · wf-form4_167356241552627.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,961 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 22:27 UTC |
Anderson Bonnie HDirector
|
Exercise / conversionCommon Stock | 63,247 | $14.34 | $906,961.98 |
DisclosureSEC source: 0001384101-23-000002 · wf-form4_167356241552627.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 22:04 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 600 | $30.13 | $18,080.16 |
DisclosureSEC source: 0001384101-22-000166 · wf-form4_167122823938243.xml · nonDerivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,184 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.02 to $30.51. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 22:00 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 300 | $31.65 | $9,493.50 |
DisclosureSEC source: 0001384101-22-000164 · wf-form4_167114160864923.xml · nonDerivative · entry 2 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,784 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2022. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $31.465 to $31.91. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 22:00 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 1,367 | $30.51 | $41,703.21 |
DisclosureSEC source: 0001384101-22-000164 · wf-form4_167114160864923.xml · nonDerivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,084 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.06 to $31.05. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 22:18 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 1,023 | $27.03 | $27,651.69 |
DisclosureSEC source: 0001384101-22-000157 · wf-form4_167053791573091.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,970 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 22:19 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Tax withholdingCommon Stock | 1,008 | $29.14 | $29,373.12 |
DisclosureSEC source: 0001384101-22-000155 · wf-form4_167036513618601.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,993 F1 · kind: The reporting person is reporting the withholding of 248, 372, and 388 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 500, 750 and 781 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 22:14 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 735 | $29.14 | $21,417.90 |
DisclosureSEC source: 0001384101-22-000153 · wf-form4_167036483697035.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,998 F1 · kind: The reporting person is reporting the withholding of 735 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,125 Restricted Stock Units granted on July 19, 2021 and does not represent a sale by the reporting person. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 22:10 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,012 | $29.14 | $29,489.68 |
DisclosureSEC source: 0001384101-22-000151 · wf-form4_167036462968825.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,299 F1 · kind: The reporting person is reporting the withholding of 1,012 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,926 Restricted Stock Units granted on June 1, 2021 and does not represent a sale by the reporting person. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 22:07 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
Tax withholdingCommon Stock | 2,042 | $29.14 | $59,503.88 |
DisclosureSEC source: 0001384101-22-000149 · wf-form4_167036442737005.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,961 F1 · kind: The reporting person is reporting the withholding of 738, 812, and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020 and February 26, 2021 respectively, and does not represent a sale by the reporting person. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.61 | $0.00 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · derivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,117 Underlying: Common Stock · 30,000 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $14.34 | $0.00 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 50,000 shares Expires 2024-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
SaleCommon Stock | 45,460 | $28.60 | $1,300,301.47 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,003 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.21 to $28.85. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
SaleCommon Stock | 34,540 | $27.81 | $960,446.87 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,463 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $27.20 to $28.20. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
Exercise / conversionCommon Stock | 30,000 | $5.61 | $168,300.00 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
Exercise / conversionCommon Stock | 50,000 | $14.34 | $717,000.00 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 21:54 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 100 | $31.02 | $3,102.03 |
DisclosureSEC source: 0001384101-22-000143 · wf-form4_166854926790911.xml · nonDerivative · entry 2 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,451 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2022. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $31.02 to $31.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 21:54 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 5,900 | $30.21 | $178,254.93 |
DisclosureSEC source: 0001384101-22-000143 · wf-form4_166854926790911.xml · nonDerivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,551 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.945. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 22:02 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2 | $0.00 Strike: $14.34 | $0.00 |
DisclosureSEC source: 0001384101-22-000145 · wf-form4_166854970597951.xml · derivative · entry 3 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 22:02 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 2 | $29.34 | $58.68 |
DisclosureSEC source: 0001384101-22-000145 · wf-form4_166854970597951.xml · nonDerivative · entry 2 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,001 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 22:02 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 2 | $14.34 | $28.68 |
DisclosureSEC source: 0001384101-22-000145 · wf-form4_166854970597951.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022. Read SEC document |
| November 04, 2022 Filed Nov 8, 2022 22:44 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 1,023 | $25.00 | $25,575.00 |
DisclosureSEC source: 0001384101-22-000141 · wf-form4_166794747255272.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,001 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:05 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,244 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001384101-22-000134 · wf-form4_166604061306981.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,756 Underlying: Common Stock · 9,244 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:05 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,844 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001384101-22-000134 · wf-form4_166604061306981.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,844 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:05 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
Exercise / conversionCommon Stock | 9,244 | $9.05 | $83,658.20 |
DisclosureSEC source: 0001384101-22-000134 · wf-form4_166604061306981.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:05 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
Exercise / conversionCommon Stock | 1,844 | $8.86 | $16,337.84 |
DisclosureSEC source: 0001384101-22-000134 · wf-form4_166604061306981.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:57 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Tax withholdingCommon Stock | 1,008 | $19.18 | $19,333.44 |
DisclosureSEC source: 0001384101-22-000131 · wf-form4_166258421424158.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,024 F1 · kind: The reporting person is reporting the withholding of 248, 372, and 388 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 500, 750 and 781 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:56 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,012 | $19.18 | $19,410.16 |
DisclosureSEC source: 0001384101-22-000130 · wf-form4_166258419155181.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,311 F1 · kind: The reporting person is reporting the withholding of 1,012 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,925 Restricted Stock Units granted on June 1, 2021 and does not represent a sale by the reporting person. F2 · balance_after: Includes 562 shares of common stock purchased on July 29, 2022 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:56 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 3,023 | $19.18 | $57,981.14 |
DisclosureSEC source: 0001384101-22-000129 · wf-form4_166258416622084.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,733 F1 · kind: The reporting person is reporting the withholding of 3,023 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 8,500 Restricted Stock Units granted on July 19, 2021 and does not represent a sale by the reporting person. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:56 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
Tax withholdingCommon Stock | 2,042 | $19.18 | $39,165.56 |
DisclosureSEC source: 0001384101-22-000128 · wf-form4_166258414781633.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,003 F1 · kind: The reporting person is reporting the withholding of 738, 812, and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 2,063 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020 and February 26, 2021 respectively, and does not represent a sale by the reporting person. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:28 UTC |
Barr EliavDirector
|
GrantCommon Stock | 20,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-22-000123 · wf-form4_166024966937057.xml · nonDerivative · entry 1 Barr Eliav · CIK 0001940521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,721 F1 · kind: Restricted stock units awarded on August 9, 2022 vest as to one-third (1/3) of the shares on each of the first, second and third annual anniversaries of the date of grant. F2 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 21:16 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
SaleCommon Stock | 5,769 | $27.82 | $160,497.04 |
DisclosureSEC source: 0001384101-22-000114 · wf-form4_166007979365285.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Indirect · The Bonnie H. Anderson Living Trust Disclosed balance after: 112,426 F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $27.730 to $27.935. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 21:16 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
SaleCommon Stock | 39,231 | $27.24 | $1,068,577.90 |
DisclosureSEC source: 0001384101-22-000114 · wf-form4_166007979365285.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Indirect · The Bonnie H. Anderson Living Trust Disclosed balance after: 118,195 F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.710 to $27.705. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:19 UTC |
McGuire AnnieSVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 18,248 | $0.00 Strike: $27.90 | $0.00 |
DisclosureSEC source: 0001384101-22-000117 · wf-form4_166007992573625.xml · derivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,248 Underlying: Common Stock · 18,248 shares Expires 2032-08-05 F2 · derivative.exercise_date: The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:19 UTC |
McGuire AnnieSVP, General Counsel
|
GrantCommon Stock | 10,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-22-000117 · wf-form4_166007992573625.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,557 F1 · kind: Restricted stock units awarded on August 5, 2022 vest 1/3rd on September 2, 2023 and 1/12th per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:18 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
GrantStock Option (right to buy) · Derivative | 14,598 | $0.00 Strike: $27.90 | $0.00 |
DisclosureSEC source: 0001384101-22-000116 · wf-form4_166007984477764.xml · derivative · entry 2 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,598 Underlying: Common Stock · 14,598 shares Expires 2032-08-05 F2 · derivative.exercise_date: The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:18 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
GrantCommon Stock | 8,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-22-000116 · wf-form4_166007984477764.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,561 F1 · kind: Restricted stock units awarded on August 5, 2022 vest 1/3rd on September 2, 2023 and 1/12th per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:17 UTC |
Chambers RebeccaChief Financial Officer
|
GrantCommon Stock · Derivative | 36,496 | $0.00 Strike: $27.90 | $0.00 |
DisclosureSEC source: 0001384101-22-000115 · wf-form4_166007981918123.xml · derivative · entry 2 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,496 Underlying: Stock Option (right to buy) · 36,496 shares Expires 2032-08-05 F3 · derivative.exercise_date: The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:17 UTC |
Chambers RebeccaChief Financial Officer
|
GrantCommon Stock | 21,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-22-000115 · wf-form4_166007981918123.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,756 F1 · kind: Restricted stock units awarded on August 5, 2022 vest 1/3rd on September 2, 2023 and 1/12th per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. F2 · balance_after: Includes 624 shares of common stock purchased on July 29, 2022 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:16 UTC |
Anderson Bonnie HDirector · Executive Chairwoman
|
SaleCommon Stock | 76,917 | $27.71 | $2,131,370.07 |
DisclosureSEC source: 0001384101-22-000114 · wf-form4_166007979365285.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Indirect · The Bonnie H. Anderson Living Trust Disclosed balance after: 157,426 F1 · price: Represents weighted average sales price. Sale prices for the transactions range from $27.09 to $28.06. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1 | $0.00 Strike: $5.43 | $0.00 |
DisclosureSEC source: 0001384101-22-000113 · wf-form4_166007975334441.xml · derivative · entry 9 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2 | $0.00 Strike: $6.45 | $0.00 |
DisclosureSEC source: 0001384101-22-000113 · wf-form4_166007975334441.xml · derivative · entry 8 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2 | $0.00 Strike: $10.45 | $0.00 |
DisclosureSEC source: 0001384101-22-000113 · wf-form4_166007975334441.xml · derivative · entry 7 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2 shares Expires 2024-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
GrantStock Option (right to buy) · Derivative | 18,248 | $0.00 Strike: $27.90 | $0.00 |
DisclosureSEC source: 0001384101-22-000113 · wf-form4_166007975334441.xml · derivative · entry 6 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,248 Underlying: Common Stock · 18,248 shares Expires 2032-08-05 F3 · derivative.exercise_date: The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:16 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 1,028 | $26.54 | $27,283.12 |
DisclosureSEC source: 0001384101-22-000113 · wf-form4_166007975334441.xml · nonDerivative · entry 5 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,032 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.